Showing results (211-220 of 618) with videos related to
Sort By:
Pageof 62
Neuro-Oncology|February 17, 2010
Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitorsBrian J Scott, Eudocia C Quant, Margaret B McNamara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastomaLorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.IEEE Transactions on Bio-Medical Engineering|May 30, 2024
Non-Invasive Blood-Brain Barrier Disruption Using Acoustic Holography With a Clinical Focused Ultrasound SystemNathan McDannold, Yongzhi Zhang, Stecia-Marie Fletcher, et al.Neuro-Oncology Advances|February 5, 2024
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forwardEmily J Smith, Anant Naik, Mahima Goel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.The Journal of Molecular Diagnostics : JMD|July 23, 2013
The role of MGMT testing in clinical practice: a report of the association for molecular pathologyMilena Cankovic, Marina N Nikiforova, Matija Snuderl, et al.Neuro-Oncology Advances|May 4, 2026
Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic reviewMaged T Ghoche, Kenji Miki, Fanen Yuan, et al.Journal of Neuro-Oncology|May 6, 2014
Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastomaAyca Akgoz, Rifaquat Rahman, Hui You, et al.Expert Opinion on Emerging Drugs|May 15, 2013
Update on bevacizumab and other angiogenesis inhibitors for brain cancerMikael L Rinne, Eudocia Q Lee, Lakshmi Nayak, et al.Neuro-Oncology|February 8, 2025
Identifying appropriate external control datasets in support of future glioblastoma clinical trials leveraging external dataRifaquat Rahman, Steffen Ventz, Robert Redd, et al.Pageof 62